In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...

ORLANDO, Dec. 6, 2025) In a new trial , patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

Members of Fulcrum management will be joined by Dr. Sheinei Alan, Director of the Inova Adult Sickle Cell Program and Assistant Professor at UVA School of Medicine, and Dr. Martin Steinberg, Professor ...

Emerging tests and treatment strategies guide more tailored approaches and ease the burden on patientsORLANDO, Fla., Dec. 6, ...

The New Jersey Office of the Secretary of Higher Education (OSHE), in partnership with ReUp Education, today released a new impact report on the State's groundbreaking Some College, No Degree (SCND) ...

‘Chief Medical Officer’s Annual Report 2025: Infections’ was published at 15:00 UK time on Thursday the 4th of December 2025. Prof Andrew Morris: Andrew is the President of the Academy of Medical ...

Genomic Testing Cooperative (GTC), a leading provider of integrated DNA and RNA next-generation sequencing (NGS) solutions ...

NEJM Evidence, a journal of the New England Journal of Medicine Group, has published an article titled "Validation of a Saliva microRNA Signature for Endometriosis," dedicated to the saliva-based ...

Twenty-five years ago, the release of the first complete Arabidopsis thaliana genome marked a pivotal turning point in plant ...

The Hertz Foundation is proud to recognize the 16 most recent graduates of the Hertz Fellowship in applied science, mathematics and engineering.

The field of immuno-oncology (IO) has grown rapidly, with multiple therapies demonstrating significant survival benefit and becoming the standard of care for various cancers. However, more than 85% of ...